U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07158879) titled 'Skin Reactions Related to Thoracic Implantable Chamber Dressings' on July 10.
Brief Summary: Prospective, multicenter cohort of 500 patients newly treated with systemic chemotherapy with CCI. The main objective of this study is to measure the incidence of skin reactions related to thoracic implantable chamber dressings.
Study Start Date: June 10
Study Type: OBSERVATIONAL
Condition:
Skin Diseases
Recruitment Status: RECRUITING
Sponsor: Institut Curie
Published by HT Digital Content Services with permission from Health Daily Digest....